PYLARIFY (PIFLUFOLASTAT F 18)

This is a Special Notice as a Pre-Intent to Sole Source / request for information only. The responses to this posting will be used to establish the procurement strategy for example, set-aside, sole source, unrestricted for a solicitation that VA intends to post in the near future. Please review the attached document(s) for more details on this requirement. See attached document(s): 36C25624Q0396 - Request for Information (RFI) NO SOLICITATION EXISTS AT THIS TIME.

Please provide the information you deem relevant in order to respond to the specific inquiries of the RFI. Information provided will be used solely by Michael E. DeBakey VA Medical Center (MEDVAMC) as Market Research and will not be released outside of the MEDVAMC Purchasing and Contracting Team. RFI responses are due by 9:00a.m.

Central Standard Time (CST) on January 26, 2024; size is limited to 8.5 x 11 inches, 12-point font, with 1-inch margins in Microsoft Word format via email to Jeneice Matthews, jeneice.matthews@va.gov . The subject line shall read: 36C25624Q0396- Pylarify Injection-MEDVAMC.